9,464 articles
John W. Holaday
John W. Holaday (1945–2019) was an American neuropharmacologist and Army researcher who showed that endorphins contribute to shock and spinal cord injury, and later co-founded Medicis, EntreMed, and MaxCyte.
John W. Little
John W. Little is a molecular biologist at the University of Arizona known for showing that the LexA repressor self-cleaves to switch on the SOS system.
John W. Newport
John W. Newport was an American cell biologist at UC San Diego who showed how frog embryos time development and identified the kinase driving mitosis.
John W. Olney
John W. Olney (died 2015) was an American psychiatrist and neuropathologist at Washington University in St. Louis who originated excitotoxicity, the death of nerve cells from excess glutamate.
John W. R. Schwabe
John W. R. Schwabe, also published as John Schwabe, is a structural biologist and professor at the University of Leicester known for structures of nuclear receptors and HDAC complexes.
John W. Saunders, Jr.
John W. Saunders, Jr. was an American developmental biologist who discovered the apical ectodermal ridge and zone of polarizing activity, which organize vertebrate limb development.
John W.B. Hershey
John W.B. Hershey (1934–2023) was an American molecular biologist who worked out how translation, protein synthesis from messenger RNA, is initiated, at UC Davis from 1970 to 2004.
John Williamson (biochemist)
John Williamson was a biochemist at the University of Pennsylvania's Johnson Research Foundation known for work on metabolic control in the heart and liver and for NMR studies of intact, metabolizing cells and organs.
John Yates (biochemist)
John R. Yates III is an American scientist at Scripps Research in La Jolla, California, lead inventor of the SEQUEST software and a principal developer of shotgun proteomics.
John Zachary Young
John Zachary Young, known as J. Z. Young, was a British zoologist and neurophysiologist who rediscovered the squid giant axon and pioneered the octopus for memory research.
Johnatan Aljadeff
Johnatan (Yonatan) Aljadeff is a computational neuroscientist who has been on the UC San Diego neurobiology faculty since 2020, applying dynamical systems and information theory to synaptic plasticity and learning.
Johnathan R. Whetstine
Johnathan R. Whetstine is a cancer epigenetics researcher who directs the Cancer Epigenetics Institute at Fox Chase Cancer Center and helped discover JmjC histone demethylases.
Johnny Ludvigsson
Johnny Ludvigsson is a Swedish pediatrician and diabetes researcher, Professor Emeritus of Pediatrics at Linköping University, known for the Linköping Complication Study and GAD65 immunotherapy trials.
Jon Clardy
Jon Clardy is a chemical biologist who holds the Christopher T. Walsh Professorship at Harvard Medical School and studies biologically active small molecules from bacteria and fungi.
Jon Driver
Jon Driver, fully Jonathon Stevens Driver (1962–2011), was a British psychologist and cognitive neuroscientist at University College London, a leading researcher on visual neglect and multisensory integration.
Jon H. Kaas
Jon H. Kaas, born 1937 in Fargo, North Dakota, is an American neuroscientist at Vanderbilt University known for comparative mapping of sensory and motor cortex in primates.
Jon S. Thorson
Jon S. Thorson is a chemical biologist and professor at the University of Kentucky College of Pharmacy, known for developing glycorandomization, a method for attaching new sugars to drug-like natural products.
Jonah R. Chan
Jonah R. Chan is an American neuroscientist at UCSF who developed the screening platform behind the first drug shown to promote remyelination in multiple sclerosis.
Jonas Frisén
Jonas Frisén is a Swedish stem cell researcher and professor at Karolinska Institutet known for dating human cells by bomb-test carbon-14 and for showing the adult brain forms new neurons.
Jonas Ries
Jonas Ries is a German biophysicist who works on super-resolution microscopy and clathrin-mediated endocytosis, and has been a professor at the University of Vienna since 2023.
Jonas Salk
Jonas Salk (1914–1995), American virologist who developed the first safe polio vaccine, a killed-virus (IPV) formulation announced safe and 90% effective on April 12, 1955 after a 1.8-million-child trial; he never patented it and founded the Salk Institute.
Jonathan A. Cooper
Jonathan A. Cooper is an English-born cell biologist and emeritus professor at Fred Hutch Cancer Center in Seattle, best known for establishing that Ras binds directly to Raf kinase.
Jonathan A. Epstein
Jonathan A. Epstein, also known as Jonathan Epstein, is an American cardiologist and molecular biologist who became Dean of Penn's Perelman School of Medicine in 2025.
Jonathan A. Javitch
Jonathan A. Javitch, also known as Jonathan Javitch, is a physician-scientist at Columbia University and the New York State Psychiatric Institute who studies G protein-coupled receptors and neurotransmitter transporters.
Jonathan A. Raper
Jonathan A. Raper is a developmental neuroscientist and Emeritus Professor of Neuroscience at the University of Pennsylvania, known for identifying collapsin, later classed among the semaphorins.
Jonathan Abraham
Jonathan Abraham is an American virologist and physician-scientist, Associate Professor of Microbiology at Harvard Medical School and an HHMI Investigator since 2024, who studies how viruses infect cells.
Jonathan Ashmore
Jonathan Ashmore, born in 1948, is a neuroscientist and the Bernard Katz Professor of Biophysics at University College London, known for his work on cochlear outer hair cells and the cochlear amplifier.
Jonathan B. Chaires
Jonathan B. Chaires, also published as Jonathan Chaires, is an American biophysical chemist at the University of Louisville known for research on nucleic acids, G-quadruplexes, and drug-DNA interactions.
Jonathan B. Rothbard
Jonathan B. Rothbard is an American organic chemist and immunologist at Stanford University, known for a 1988 model of T-cell antigen recognition and peptide drug delivery.
Jonathan C. Cohen
Jonathan C. Cohen is an American human geneticist at UT Southwestern who, with Helen Hobbs, used the Dallas Heart Study to show PCSK9 mutations lower LDL cholesterol and heart disease risk.